Ambu, Aura Gain - Single Use Laryngeal Mask- Sterile for use as an alternative to a face mask f...
FDA Device Recall #Z-1236-2016 — Class II — February 10, 2016
Recall Summary
| Recall Number | Z-1236-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | February 10, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Ambu Inc. |
| Location | Columbia, MD |
| Product Type | Devices |
| Quantity | Total Numbers of unit distributed: 45990 pes (USA) |
Product Description
Ambu, Aura Gain - Single Use Laryngeal Mask- Sterile for use as an alternative to a face mask for achieving and maintaining control of the airway during routine emergency anesthetic procedures.
Reason for Recall
Ambu, Aura Gain laryngeal Mask, was found to have lack of Sterility Assurance. The firm discovered the problem during final quality control at manufacturing site. Damage to the sterile barrier (the pouch) may compromise a medical device's sterility,leading to contamination of the product and,ultimately,patient complications.
Distribution Pattern
Please see attached consignee list
Lot / Code Information
Catalog Number:408300000 Size #3:All lots from 1632796 through lot number 1808911except lot number 1779966,1782239, 1795914 Catalog Number: 408400000 Size #4 All lots from 1632799 through lot number 1790075. Catalog Number:408500000 Size #5 All lots from 1632802 through lot number 1810863.
Other Recalls from Ambu Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2181-2025 | Class I | Ambu SPUR II Labeled as the following: 1 SPUR I... | Jul 9, 2025 |
| Z-1723-2025 | Class II | Ambu aScope" 5 Broncho HD 5.6/2.8 Sampler Set. ... | Apr 7, 2025 |
| Z-0261-2025 | Class II | Ambu¿ VivaSight 2 DLT Endobronchial tube, 35 FR... | Sep 16, 2024 |
| Z-0714-2024 | Class II | Ambu aView 2 A Monitor, Catalog numbers 4050110... | Dec 5, 2023 |
| Z-2628-2023 | Class II | Ambu aView 2 A Monitor-The Ambu aView 2 Advance... | Jul 21, 2023 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.